APO Research
Talk to an analyst

APO RESEARCH · REPORT

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032

23 December 2025112 pages

Choose your research edition.

Industry ResearchPorcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include China Animal Husbandry Co., Ltd., Yongshun Biological, Tiankang, Zoetis, Ruipu Biological, Qilu Animal Health, Pulike Biological, Jinyu and Sinopharm Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Company

China Animal Husbandry Co., Ltd.

Yongshun Biological

Tiankang

Zoetis

Ruipu Biological

Qilu Animal Health

Pulike Biological

Jinyu

Sinopharm Animal Health

Dahuanong

Boehringer Ingelheim

Phibro Animal Health

MSD Animal Health

Komipharm

Ceva

CAVAC

Bioveta

Agrovet

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type

Live vaccines

Inactivated vaccines

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application

Government bidding

Market sales

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live vaccines Table 2. Major Company of Inactivated vaccines Table 3. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2026) & (USD/unit) Table 9. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2027-2032) & (USD/unit) Table 14. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends Table 25. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers Table 26. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges Table 27. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints Table 28. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Company (2021-2026) Table 32. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Company Production Sites and Headquarters Table 35. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company, Product Type & Application Table 36. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2026) & (USD/unit) Table 56. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2027-2032) & (USD/unit) Table 61. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. China Animal Husbandry Co., Ltd. Company Information Table 72. China Animal Husbandry Co., Ltd. Business Overview Table 73. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 75. China Animal Husbandry Co., Ltd. Recent Development Table 76. Yongshun Biological Company Information Table 77. Yongshun Biological Business Overview Table 78. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 80. Yongshun Biological Recent Development Table 81. Tiankang Company Information Table 82. Tiankang Business Overview Table 83. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 85. Tiankang Recent Development Table 86. Zoetis Company Information Table 87. Zoetis Business Overview Table 88. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 90. Zoetis Recent Development Table 91. Ruipu Biological Company Information Table 92. Ruipu Biological Business Overview Table 93. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 95. Ruipu Biological Recent Development Table 96. Qilu Animal Health Company Information Table 97. Qilu Animal Health Business Overview Table 98. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 100. Qilu Animal Health Recent Development Table 101. Pulike Biological Company Information Table 102. Pulike Biological Business Overview Table 103. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 105. Pulike Biological Recent Development Table 106. Jinyu Company Information Table 107. Jinyu Business Overview Table 108. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 110. Jinyu Recent Development Table 111. Sinopharm Animal Health Company Information Table 112. Sinopharm Animal Health Business Overview Table 113. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 115. Sinopharm Animal Health Recent Development Table 116. Dahuanong Company Information Table 117. Dahuanong Business Overview Table 118. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 120. Dahuanong Recent Development Table 121. Boehringer Ingelheim Company Information Table 122. Boehringer Ingelheim Business Overview Table 123. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 125. Boehringer Ingelheim Recent Development Table 126. Phibro Animal Health Company Information Table 127. Phibro Animal Health Business Overview Table 128. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 130. Phibro Animal Health Recent Development Table 131. MSD Animal Health Company Information Table 132. MSD Animal Health Business Overview Table 133. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 135. MSD Animal Health Recent Development Table 136. Komipharm Company Information Table 137. Komipharm Business Overview Table 138. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 140. Komipharm Recent Development Table 141. Ceva Company Information Table 142. Ceva Business Overview Table 143. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 145. Ceva Recent Development Table 146. CAVAC Company Information Table 147. CAVAC Business Overview Table 148. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 150. CAVAC Recent Development Table 151. Bioveta Company Information Table 152. Bioveta Business Overview Table 153. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 155. Bioveta Recent Development Table 156. Agrovet Company Information Table 157. Agrovet Business Overview Table 158. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 160. Agrovet Recent Development Table 161. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 163. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 164. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 165. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 166. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 168. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 169. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 171. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 173. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 174. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 175. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 176. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 178. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 179. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 183. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 184. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 185. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 188. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 189. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 191. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 192. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 193. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 194. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 195. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 196. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 198. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 199. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 203. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 204. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 205. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 208. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 209. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 214. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Image Figure 2. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032) & (k units) Figure 5. Live vaccines Image Figure 6. Global Live vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Inactivated vaccines Image Figure 8. Global Inactivated vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Government bidding Image Figure 24. Global Government bidding Sales YoY Growth (2021-2032) & (k units) Figure 25. Market sales Image Figure 26. Global Market sales Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Live vaccines
  • Inactivated vaccines
Applications
  • Government bidding
  • Market sales
Companies covered
  • China Animal Husbandry Co., Ltd.
  • Yongshun Biological
  • Tiankang
  • Zoetis
  • Ruipu Biological
  • Qilu Animal Health
  • Pulike Biological
  • Jinyu
  • Sinopharm Animal Health
  • Dahuanong
  • Boehringer Ingelheim
  • Phibro Animal Health
  • MSD Animal Health
  • Komipharm
  • Ceva
  • CAVAC
  • Bioveta
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Type
  6. 1.3.1 Live vaccines
  7. 1.3.2 Inactivated vaccines
  8. 1.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  9. 1.4.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
  2. 2.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers
  3. 2.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges
  4. 2.4 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (2021-2026)
  4. 3.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company, Product Type & Application
  7. 3.7 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Tier 1, Tier 2, and Tier 3
4 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Regional Status and Outlook
  1. 4.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size by Region
  3. 4.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application
  1. 5.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Application
  2. 5.1.1 Government bidding
  3. 5.1.2 Market sales
  4. 5.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  5. 5.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 China Animal Husbandry Co., Ltd.
  2. 6.1.1 China Animal Husbandry Co., Ltd. Company Information
  3. 6.1.2 China Animal Husbandry Co., Ltd. Business Overview
  4. 6.1.3 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  6. 6.1.5 China Animal Husbandry Co., Ltd. Recent Developments
  7. 6.2 Yongshun Biological
  8. 6.2.1 Yongshun Biological Company Information
  9. 6.2.2 Yongshun Biological Business Overview
  10. 6.2.3 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  12. 6.2.5 Yongshun Biological Recent Developments
  13. 6.3 Tiankang
  14. 6.3.1 Tiankang Company Information
  15. 6.3.2 Tiankang Business Overview
  16. 6.3.3 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  18. 6.3.5 Tiankang Recent Developments
  19. 6.4 Zoetis
  20. 6.4.1 Zoetis Company Information
  21. 6.4.2 Zoetis Business Overview
  22. 6.4.3 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  24. 6.4.5 Zoetis Recent Developments
  25. 6.5 Ruipu Biological
  26. 6.5.1 Ruipu Biological Company Information
  27. 6.5.2 Ruipu Biological Business Overview
  28. 6.5.3 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  30. 6.5.5 Ruipu Biological Recent Developments
  31. 6.6 Qilu Animal Health
  32. 6.6.1 Qilu Animal Health Company Information
  33. 6.6.2 Qilu Animal Health Business Overview
  34. 6.6.3 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  36. 6.6.5 Qilu Animal Health Recent Developments
  37. 6.7 Pulike Biological
  38. 6.7.1 Pulike Biological Company Information
  39. 6.7.2 Pulike Biological Business Overview
  40. 6.7.3 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  42. 6.7.5 Pulike Biological Recent Developments
  43. 6.8 Jinyu
  44. 6.8.1 Jinyu Company Information
  45. 6.8.2 Jinyu Business Overview
  46. 6.8.3 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  48. 6.8.5 Jinyu Recent Developments
  49. 6.9 Sinopharm Animal Health
  50. 6.9.1 Sinopharm Animal Health Company Information
  51. 6.9.2 Sinopharm Animal Health Business Overview
  52. 6.9.3 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  54. 6.9.5 Sinopharm Animal Health Recent Developments
  55. 6.10 Dahuanong
  56. 6.10.1 Dahuanong Company Information
  57. 6.10.2 Dahuanong Business Overview
  58. 6.10.3 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  60. 6.10.5 Dahuanong Recent Developments
  61. 6.11 Boehringer Ingelheim
  62. 6.11.1 Boehringer Ingelheim Company Information
  63. 6.11.2 Boehringer Ingelheim Business Overview
  64. 6.11.3 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  66. 6.11.5 Boehringer Ingelheim Recent Developments
  67. 6.12 Phibro Animal Health
  68. 6.12.1 Phibro Animal Health Company Information
  69. 6.12.2 Phibro Animal Health Business Overview
  70. 6.12.3 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  72. 6.12.5 Phibro Animal Health Recent Developments
  73. 6.13 MSD Animal Health
  74. 6.13.1 MSD Animal Health Company Information
  75. 6.13.2 MSD Animal Health Business Overview
  76. 6.13.3 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  78. 6.13.5 MSD Animal Health Recent Developments
  79. 6.14 Komipharm
  80. 6.14.1 Komipharm Company Information
  81. 6.14.2 Komipharm Business Overview
  82. 6.14.3 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  84. 6.14.5 Komipharm Recent Developments
  85. 6.15 Ceva
  86. 6.15.1 Ceva Company Information
  87. 6.15.2 Ceva Business Overview
  88. 6.15.3 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  90. 6.15.5 Ceva Recent Developments
  91. 6.16 CAVAC
  92. 6.16.1 CAVAC Company Information
  93. 6.16.2 CAVAC Business Overview
  94. 6.16.3 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  96. 6.16.5 CAVAC Recent Developments
  97. 6.17 Bioveta
  98. 6.17.1 Bioveta Company Information
  99. 6.17.2 Bioveta Business Overview
  100. 6.17.3 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  102. 6.17.5 Bioveta Recent Developments
  103. 6.18 Agrovet
  104. 6.18.1 Agrovet Company Information
  105. 6.18.2 Agrovet Business Overview
  106. 6.18.3 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  108. 6.18.5 Agrovet Recent Developments
7 North America by Country
  1. 7.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 7.1.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 7.2.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 8.1.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 8.2.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 10.1.1 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 10.2.1 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Analysis
  2. 12.1.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
  7. 12.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
  10. 12.2.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst